The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
New synthetic opioids (NSOs) are one of the fastest-growing groups of new psychoactive substances around the world ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...